Overcoming Weaknesses of Current In Vitro Models using Novel In Vivo Approaches

Time: 12:00 pm
day: Day One Track A AM


  • Investigating key factors contributing to tumorigenesis in iPSCs to identify areas in need of greater attention during cell reprogramming and differentiation
  • Employing in vitro and in vivo models to assess the tumorigenic potential of iPSC-derived cells, facilitating the selection of safer cell lines for therapeutic development
  • Mitigating tumorigenicity risks throughout preclinical development, ultimately enhancing the safety and efficacy of iPSC-based therapies